These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2949275)
1. [Piperacillin in in vitro-in vivo combination]. Ferre B; Acar JF Presse Med; 1986 Dec; 15(46):2317-20. PubMed ID: 2949275 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic considerations in using combinations of newer beta-lactam antibiotics. Barriere SL Clin Pharm; 1986 Jan; 5(1):24-33. PubMed ID: 3512153 [TBL] [Abstract][Full Text] [Related]
4. Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy. Winston DJ; Ho WG; Champlin RE; Gale RP; Busuttil RW J Antimicrob Chemother; 1986 Mar; 17 Suppl A():55-66. PubMed ID: 3086277 [TBL] [Abstract][Full Text] [Related]
5. [Piperacillin/tazobactam--Tazocin. A penicillin-based alternative to 3rd generation cephalosporins and carbapenems]. Schønning K; Tvede M Ugeskr Laeger; 2002 May; 164(20):2606-10. PubMed ID: 12043402 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and tolerance of piperacillin in 333 patients]. Mouton Y; Beuscart C; Soussy C Presse Med; 1986 Dec; 15(46):2347-50. PubMed ID: 2949284 [TBL] [Abstract][Full Text] [Related]
7. [Antibacterial combination therapy]. Tauchnitz C Z Gesamte Inn Med; 1977 Jul; 32(14):Suppl 219-22. PubMed ID: 919646 [TBL] [Abstract][Full Text] [Related]
8. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors. Weiss WJ; Petersen PJ; Murphy TM; Tardio L; Yang Y; Bradford PA; Venkatesan AM; Abe T; Isoda T; Mihira A; Ushirogochi H; Takasake T; Projan S; O'Connell J; Mansour TS Antimicrob Agents Chemother; 2004 Dec; 48(12):4589-96. PubMed ID: 15561830 [TBL] [Abstract][Full Text] [Related]
10. Antibiotics in the second half of the 1980s. Areas of future development and the effect of new agents on aminoglycoside use. Neu HC Am J Med; 1986 Jun; 80(6B):195-203. PubMed ID: 3460336 [TBL] [Abstract][Full Text] [Related]
12. Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Gribble MJ; Chow AW; Naiman SC; Smith JA; Bowie WR; Sacks SL; Grossman L; Buskard N; Growe GH; Plenderleith LH Antimicrob Agents Chemother; 1983 Sep; 24(3):388-93. PubMed ID: 6357076 [TBL] [Abstract][Full Text] [Related]
13. [In vivo combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa]. Sato K; Yamashita K; Okachi R Jpn J Antibiot; 1986 Jun; 39(6):1487-93. PubMed ID: 3093728 [TBL] [Abstract][Full Text] [Related]
14. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Powell LL; Wilson SE Surg Infect (Larchmt); 2000; 1(1):57-63. PubMed ID: 12594910 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides? Harris PN; Ferguson JK Int J Antimicrob Agents; 2012 Oct; 40(4):297-305. PubMed ID: 22824371 [TBL] [Abstract][Full Text] [Related]
17. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution? Nichols L; Maki DG Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938 [TBL] [Abstract][Full Text] [Related]
18. Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). Hanberger H; Edlund C; Furebring M; G Giske C; Melhus A; Nilsson LE; Petersson J; Sjölin J; Ternhag A; Werner M; Eliasson E; Scand J Infect Dis; 2013 Mar; 45(3):161-75. PubMed ID: 23270477 [TBL] [Abstract][Full Text] [Related]
19. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units]. Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273 [TBL] [Abstract][Full Text] [Related]
20. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia. Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]